Post-Operative Pain Global Clinical Trials Review, H1, 2016

GlobalData
1697 Pages - GLDATA52813
$2,500.00

Summary

GlobalData's clinical trial report, “Post-Operative Pain Global Clinical Trials Review, H1, 2016" provides an overview of Post-Operative Pain clinical trials scenario. This report provides top line data relating to the clinical trials on Post-Operative Pain. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional and country level

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Companies Mentioned

Pfizer Inc.
Pacira Pharmaceuticals, Inc.
Johnson & Johnson
Merck & Co., Inc.
Premier Research Group Limited
Lotus Clinical Research, LLC
Grunenthal GmbH
Mundipharma International Ltd
Mallinckrodt Plc
Jean Brown Research

'

Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Report Guidance 5
Clinical Trials by Region 6
Clinical Trials and Average Enrollment by Country 7
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Five Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Post-Operative Pain to Central Nervous System Clinical Trials 15
Clinical Trials by Phase in G7 Countries 17
Clinical Trials in G7 Countries by Trial Status 18
Clinical Trials by E7 Countries: Proportion of Post-Operative Pain to Central Nervous System Clinical Trials 19
Clinical Trials by Phase in E7 Countries 21
Clinical Trials in E7 Countries by Trial Status 22
Clinical Trials by Phase 23
In Progress Trials by Phase 24
Clinical Trials by Trial Status 25
Clinical Trials by End Point Status 26
Subjects Recruited Over a Period of Time 27
Clinical Trials by Sponsor Type 28
Prominent Sponsors 29
Top Companies Participating in Post-Operative Pain Therapeutics Clinical Trials 30
Prominent Drugs 32
Latest Clinical Trials News on Post-Operative Pain 33
Mar 07, 2016: AcelRx Pharmaceuticals Initiates Phase 3 Study of ARX-04 in Patients with Post-Operative Moderate-to-Severe Acute Pain 33
Feb 25, 2016: AcelRx Pharmaceuticals Moderate-to-Severe Acute Pain Candidate ARX-04 Shows Improved Pain Scores in ER Patients in Interim Phase 3 Analysis 33
Feb 01, 2016: Recro Pharma Initiates Second Pivotal Phase III Clinical Trial of IV Meloxicam for Acute Postoperative Pain 34
Jan 27, 2016: Recro Pharma Initiates Pivotal Phase III Clinical Trial of IV Meloxicam for Acute Postoperative Pain 34
Jan 21, 2016: AcelRx Pharmaceuticals Announces Presentation of Phase 3 Sufentanil Sublingual 30 mcg Tablet (ARX-04) Data at the European Congress of Ambulatory Surgery 35
Jan 08, 2016: AcelRx Completes Protocol Review with FDA and Plans to Initiate Phase 3 Open-Label Study (IAP312) for Zalviso in 1Q 2016 35
Clinical Trial Profile Snapshots 37
Appendix 1694
Abbreviations 1694
Definitions 1694
Research Methodology 1695
Secondary Research 1695
About GlobalData 1696
Contact Us 1696
Disclaimer 1696
Source 1697

List of Tables
Post-Operative Pain Therapeutics, Global, Clinical Trials by Region, 2016* 6
Post-Operative Pain Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 8
Post-Operative Pain Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 9
Post-Operative Pain Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2016* 10
Post-Operative Pain Therapeutics Clinical Trials, Europe, Top Five Countries, 2016* 11
Post-Operative Pain Therapeutics Clinical Trials, North America, Top Countries, 2016* 12
Post-Operative Pain Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2016* 13
Post-Operative Pain Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2016* 14
Proportion of Post-Operative Pain to Central Nervous System Clinical Trials, G7 Countries (%), 2016* 16
Post-Operative Pain Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 17
Post-Operative Pain Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 18
Proportion of Post-Operative Pain to Central Nervous System Clinical Trials, E7 Countries (%), 2016* 20
Post-Operative Pain Therapeutics, E7 Countries, Clinical Trials by Phase, 2016* 21
Post-Operative Pain Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016* 22
Post-Operative Pain Therapeutics, Global, Clinical Trials by Phase, 2016* 23
Post-Operative Pain Therapeutics, Global, Clinical Trials In Progress by Phase 2016* 24
Post-Operative Pain Therapeutics, Global, Clinical Trials by Trial Status, 2016* 25
Post-Operative Pain Therapeutics Clinical Trials, Global, by End Point Status, 2016* 26
Post-Operative Pain Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 27
Post-Operative Pain Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2016* 28
Post-Operative Pain Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 29
Post-Operative Pain Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 31
Post-Operative Pain Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 32

List of Figures
Post-Operative Pain Therapeutics, Global, Clinical Trials by Region (%), 2016* 6
Post-Operative Pain Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 7
Post-Operative Pain Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 9
Post-Operative Pain Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2016* 10
Post-Operative Pain Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2016* 11
Post-Operative Pain Therapeutics Clinical Trials, North America, Top Countries (%), 2016* 12
Post-Operative Pain Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2016* 13
Post-Operative Pain Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2016* 14
Proportion of Post-Operative Pain to Central Nervous System Clinical Trials, G7 Countries (%), 2016* 15
Post-Operative Pain Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 17
Post-Operative Pain Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 18
Proportion of Post-Operative Pain to Central Nervous System Clinical Trials, E7 Countries (%), 2016* 19
Post-Operative Pain Therapeutics, E7 Countries, Clinical Trials by Phase, 2016* 21
Post-Operative Pain Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016* 22
Post-Operative Pain Therapeutics, Global, Clinical Trials by Phase (%), 2016* 23
Post-Operative Pain Therapeutics, Global, Clinical Trials In Progress by Phase, 2016* 24
Post-Operative Pain Therapeutics, Global, Clinical Trials by Trial Status, 2016* 25
Post-Operative Pain Therapeutics Clinical Trials, Global, by End Point Status, 2016* 26
Post-Operative Pain Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 27
Post-Operative Pain Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2016* 28
Post-Operative Pain Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 29
Post-Operative Pain Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 30
Post-Operative Pain Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 32
GlobalData Methodology 1695

$2,500.00

Research Assistance

We can help you find
data and analyses
relevant to your needs,
or prepare a custom report.

Please contact us at [email protected]
or +1 212 564 2838

 

Custom Research

Contact us to speak
with your industry analyst.

[email protected] 
+1 212 564 2838

 



Discount Codes

Request Discount Codes
for reports of interest to you.

[email protected]
+1 212 564 2838



Browse All Reports